Oculoplastics

Mycophenolate mofetil (MMF) appears safe and effective as a second-line immunosuppressive agent in patients with thyroid eye disease (TED), according to a study.

In this retrospective cohort study, 20 patients with active moderate-severe to sight-threatening TED were followed over 4 years (Weeks 24, 52 and 78) to evaluate the clinical efficacy of MMF dosing and side effects.

The median…


View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. May 04, 2021

What is a Rainbow Brow?

In a presentation at ARVO 2021, Emery Jamerson, MD, described “Rainbow Brow”- a novel physical exam finding in patients with thyroid eye disease (TED). Eyes with Rainbow Brow have a statistically significant difference in eyebrow curvature than eyes with TED without it.

Researchers…

Journal Scan

  1. Jun 02, 2021

Mycophenolate mofetil appears to be effective second-line treatment for TED

Mycophenolate mofetil (MMF) appears safe and effective as a second-line immunosuppressive agent in patients with thyroid eye disease (TED), according to a study.

In this…